Sleep has been postulated to promote brain energy restoration. It is as yet unknown if increasing the energy availability within the brain reduces sleep need. The guanidine amino acid creatine (Cr) is a well-known energy booster in cellular energy homeostasis. Oral Cr-monohydrate supplementation (CS) increases exercise performance and has been shown to have substantial effects on cognitive performance, neuroprotection and circadian rhythms. The effect of CS on cellular high-energy molecules and sleep-wake behaviour is unclear. Here, we examined the sleep-wake behaviour and brain energy metabolism before and after 4-week-long oral administration of CS in the rat. CS decreased total sleep time and non-rapid eye movement (NREM) sleep significantly during the light (inactive) but not during the dark (active) period. NREM sleep and NREM delta activity were decreased significantly in CS rats after 6 h of sleep deprivation. Biochemical analysis of brain energy metabolites showed a tendency to increase in phosphocreatine after CS, while cellular adenosine triphosphate (ATP) level decreased. Microdialysis analysis showed that the sleep deprivation-induced increase in extracellular adenosine was attenuated after CS. These results suggest that CS reduces sleep need and homeostatic sleep pressure in rats, thereby indicating its potential in the treatment of sleep-related disorders.
Sleep has been postulated to promote brain energy restoration. It is as yet unknown if increasing the energy availability within the brain reduces sleep need. The guanidine amino acid creatine (Cr) is a well-known energy booster in cellular energy homeostasis. Oral Cr-monohydrate supplementation (CS) increases exercise performance and has been shown to have substantial effects on cognitive performance, neuroprotection and circadian rhythms. The effect of CS on cellular high-energy molecules and sleep-wake behaviour is unclear. Here, we examined the sleep-wake behaviour and brain energy metabolism before and after 4-week-long oral administration of CS in the rat. CS decreased total sleep time and non-rapid eye movement (NREM) sleep significantly during the light (inactive) but not during the dark (active) period. NREM sleep and NREM delta activity were decreased significantly in CS rats after 6 h of sleep deprivation. Biochemical analysis of brain energy metabolites showed a tendency to increase in phosphocreatine after CS, while cellular adenosine triphosphate (ATP) level decreased. Microdialysis analysis showed that the sleep deprivation-induced increase in extracellular adenosine was attenuated after CS. These results suggest that CS reduces sleep need and homeostatic sleep pressure in rats, thereby indicating its potential in the treatment of sleep-related disorders.
IN TROD UCTI ON
Sleep is an essential state, proved by the fact that one-third of our life is spent sleeping. While increasing evidence indicates that adequate sleep is essential for key brain functions, sleep loss and associated health issues are frequent among many adults and adolescents. A long-lasting hypothesis postulates that the function of sleep is to restore brain energy expended during active waking (Benington and Heller, 1995) . Several direct and indirect measurements of energy metabolism indicate that during sleep brain energy expenditure decreases (Madsen and Vorstrup, 1991; Maquet, 1995) . Compared with wakefulness or rapid eye movement (REM) sleep, during non-REM (NREM) sleep brain energy demand is reduced, as indicated by a 44% reduction in the cerebral metabolic rate (CMR) of glucose and a 25% reduction in the CMR of oxygen, while glucose and adenosine triphosphate (ATP) concentrations increase (Dworak et al., 2010; Netchiporouk et al., 2001) . In contrast, prolonged sleep deprivation is associated with brain energy utilization (Dworak et al., 2007 (Dworak et al., , 2010 Kong et al., 2002) . Energy depletion in localized brain areas enhances sleep (Kalinchuk et al., 2003) .
The direct relationship between wake-related neuronal activation and increased brain energy use was also addressed in our previous reports, where the metabolic by-product of energy, adenosine (AD), increased extracellularly in a wake-active brain region, the basal forebrain, during sleep deprivation (Brown et al., 2012; Porkka-Heiskanen et al., 1997) . If brain energy depletion induces NREM sleep, and NREM sleep is essential for brain energy homeostasis, an increase in brain energy availability may reduce homeostatic NREM sleep need. Cellular energy demand and supply are regulated tightly for efficiency and economy of energy use. Cells with high and fluctuating energy requirements, such as neurones, can increase the rate of ATP hydrolysis significantly (Alle et al., 2009; Attwell and Laughlin, 2001) . Under normal circumstances, intracellular ATP levels remain constant. However, under situations of increased neuronal activity such as sleep deprivation, ATP and AD concentrations vary and affect cellular signalling and vigilance via ATP receptors (P2X, P2Y) and AD receptors (Burnstock et al., 2011; Harris et al., 2012) .
The guanidine amino acid Cr is an essential molecule in cellular ATP homeostasis, particularly in tissues subject to high metabolic demands such as brain and muscle. A growing number of reports now provide evidence for the importance of the Cr kinase/phosphocreatine (CK/PCr) system and Cr metabolism for normal function of the brain, as well as under neuropathological conditions. Chronic oral Cr supplementation protects neurones in animal models of amyotrophic lateral sclerosis (ALS), Huntington disease, Parkinson disease and after cerebral ischaemia and traumatic brain injuries Lensman et al., 2006; Matthews et al., 1998 Matthews et al., , 1999 Sullivan et al., 2000) , and improves overall health and cognitive performance (Bender et al., 2008; Rae et al., 2003) . Furthermore, Cr has been shown to improve cognitive and psychomotor performance in sleep-deprived humans (Cook et al., 2011) .
Because sleep deprivation is associated with brain energy deficit, we hypothesize that Cr supplementation has the potential to compensate these energy-demanding challenges by increasing total energy availability within the brain. Given the potential usefulness of safe supplementation for alleviating the negative effects associated with sleep deprivation, the present study examines the effects of 4 weeks of oral CS on sleep-wake behaviour, sleep deprivation and associated changes in brain energy metabolism in an animal model.
EXPERIMEN TAL PROC EDURES Animal and surgical procedures
A total of 19 male Sprague-Dawley rats (300-400 g) used in this study were kept in a room with constant temperature (23°C) and 12-h light-dark cycle (lights on at 07:00 hours). Water and food were provided ad libitum. Under general anaesthesia [intramuscular (i.m.) ketamine 7.5 mg 100 g body weight, xylazine 0.38 mg 100 g, acepromazine 0.075 mg À1 100 g], rats were implanted with electroencephalogram (EEG) and electromyogram (EMG) electrodes. Electroencephalogram electrodes (stainless steel screws) were implanted epidurally over the frontal [primary motor, anterior/posterior (AP) = +2.0; medio-lateral (ML) = 2.0] and parietal (retrosplenial, AP = À4.0; ML = 1.0) cortices. EMG recording electrodes (silver wires covered with Teflon) were implanted into neck muscles. The EEG/EMG signals were amplified and sampled at 104 Hz (filter settings for EEG: 0.3 Hz high pass and 40 Hz low pass; for EMG: 30 Hz high pass and 100 Hz low pass). For collection of microdialysis samples (n = 7), a unilateral guide cannula (CMA/11 guide; CMA/Microdialysis, Stockholm, Sweden) was implanted targeting the basal forebrain area of horizontal and diagonal band/substantia innominate/magnocellular preoptic area (HDB/SI/MCPO), using bregma coordinates at: AP = -0.3; ML = 2.2; V = 8.8 (Paxinos & Watson, 1998) . Animals were treated in accordance with the Association for Assessment and Accreditation of Laboratory Animal Care and Use Committee at Boston VA Healthcare system, Harvard University and US National Institute of Health. Every effort was made to minimize animal suffering and to reduce the number of animals used.
After 1 week of the recovery period, rats were connected to EEG/EMG recording leads for adaptation which lasted 4 days. Before microdialysis probe insertion, rats were connected to the recording cables at 08:00 hours and EEG/ EMG was recorded continuously for at least 24 h to monitor the stabilization of EEG and sleep-wake cycles.
EEG recording and analysis
EEG recordings (acquisition using Grass Gamma version 4.3) were scored using the Rat Sleep Stager (version 3.2) in 10-s epochs manually for NREM sleep, REM sleep and wakefulness, as described previously (Ramesh et al., 2007) . 'Waking' (W) was identified by sustained EMG activity and low-amplitude, high-frequency (desynchronized) waves accompanied by movements, grooming, eating, etc., 'NREM sleep' by low EMG, high-amplitude, low-frequency EEG with increased activity in delta range (0.5-4.5 Hz) and quiet inactive state often assuming a curved posture, and 'REM sleep' with a further reduced EMG signal and low-amplitude EEG with high theta (5-9 Hz) activity. The amounts of wakefulness, NREM sleep, REM sleep and slow wave EEG power in delta range during NREM episodes after 4 weeks of Cr supplementation (CS) were compared with the recordings performed before the rats were put on a Cr diet (baseline). Thus the percentage changes of parameters in each animal were calculated.
Sleep deprivation
Sleep deprivation (SD) was performed by 'gentle handling' which, according to standard protocols (Franken et al., 1991) , involved presentation of new objects into the cage, tapping of the cage or gentle touching by a brush. SD for 6 h began at 07:00 hours and was ended at 13:00 hours. During SD, the rats continued to have access to food and water ad libitum.
Cr supplementation (CS) and feeding protocol
For microdialysis and EEG study, all rats (n = 7) were first fed standard rodent diet ad libitum for 2 weeks. Baseline experiments [EEG recordings and microdialysis sample collections for 24 h baseline sleep, 6 h SD and 6 h recovery sleep (RS)] were performed in all rats before the start of the ª 2017 European Sleep Research Society CS. They were then fed with rodent diet supplemented with 2% Cr-monohydrate (Sigma 3630) by Teklad Diets-Harlan Laboratories, Inc. (Madison, WI, USA) for 4 weeks. Twelve rats were used for tissue biochemistry, six of which were fed with Cr supplemented diet and the other six (controls) on standard diet. The initial body weight of 400.6 AE 7.4 g during BL recordings showed a normal trend increase in 4 weeks with the Cr diet (529.8 AE 14.3 g). A comparable increase in body weight was also observed in untreated rats. The effect of Cr on sleep and extracellular adenosine was determined by comparing with the baseline measurements before the start of CS. During the whole experiment, food and water were provided ad libitum.
Tissue collection, reverse-phase high-performance liquid chromatography (HPLC) determination of Cr and PCr and measurement of ATP content A group of 12 rats were used for tissue collection experiments. Tissue samples were collected on experimental days at 10:00 hours during the light period. The rats (Cr n = 6; control n = 6) were decapitated and brains removed. Coronal slices (2 mm thick) were placed carefully on dry ice (À78.5°C) in a covered Petri dish for rapid freezing and subsequent dissection. Four brain regions were dissected: frontal cortex (FC) (bregma 4.2-2.2), basal forebrain (BF) (bregma À0.26 to À1.2), cingulate cortex (CCX) (bregma À0.26 to À1.2) and the entire hippocampus (HIPP). While the brain slices freeze instantly in the Petri dish, further caution was exercised to complete dissections of brain regions, with an average time of 80 AE 9 s for all the animals; collection times did not differ between experimental groups. The dissected regions were stored at À80°C until used for biochemical measurements. PCr and Cr concentrations were measured using reverse-phase HPLC and ultraviolet (UV) detection, as described previously (Dworak et al., 2007 (Dworak et al., , 2010 Helzberg et al., 1987) . Determination of ATP was performed by a luciferin-luciferase-based assay (Lundin and Thore, 1975; McElroy and DeLuca, 1983) , a method which allowed highly reproducible results and was described in detail previously (Dworak et al., 2007 (Dworak et al., , 2010 .
Tissue samples were collected on experimental days at 10:00 hours during the light period.
Microdialysis and extracellular adenosine ([AD]ex) measurements
To determine the effect of CS on the homeostatic sleep factor AD in the basal forebrain, microdialysis probes (CMA/11, 2 mm membrane length and 0.24 mm diameter; CMA/ Microdialysis) were inserted into the guide cannulae at least 20 h before the start of the experiments in each rat. Artificial cerebrospinal fluid (aCSF) was perfused through the microdialysis probe at 1 lL min À1 . On each experimental day, microdialysis samples were collected at 30-min intervals during the course of the experiment. The sample were collected for 24 h from 07:00 to 19:00 hours on baseline day, followed by 6 h of sleep deprivation from 07:00 to 13:00 hours and subsequent 6 h of recovery sleep (13:00-19:00 hours). Collected samples were stored at À80°C until used for biochemical measurements. As the CS was continued for 4 weeks, the microdialysis probes were removed after baseline sample collection. A fresh set of probes were used after 4 weeks of CS, 20 h before the microdialysis sample collection. Adenosine levels were measured using HPLC coupled to a UV, as described previously (Dworak et al., 2010; Porkka-Heiskanen et al., 1997) . To compare the changes in [AD]ex during SD before and after the CS we chose the 07:00 hours value for each group as 100% baseline. The following hours were calculated and compared to the individual baseline value (07:00 hours) to provide an accurate between-group comparison.
Statistical analysis
Data are presented as means AE standard errors of the mean. Statistical comparisons were performed using Student's t-test or one-way analysis of variance (ANOVA) followed by Student-Neuman-Keuls post-hoc test. Pre-post comparisons (before and after treatment) were performed using the paired t-test. A P-value < 0.05 indicates statistical significance. All statistical analyses were performed using SigmaPlot version 11.0 for MS Windows (Systat Software Inc., Chicago, IL, USA).
RESULTS

Cr supplementation increases spontaneous waking time and reduces SWS
Four weeks of oral CS results in a significant increase in wake time during the light period (Cr: 61.4 AE 6.4%; prediet control: 43.7 AE 7.7%; P = 0.014) but not during the dark period in rats (Cr: 75.0 AE 6.8%; prediet control: 79.1 AE 4.9%; P = 0.158) (Fig. 1a) . Wake time was increased in the initial hours during the light period. Significantly higher levels (*P < 0.05; data for 24 h measurements were tested by using one-way ANOVA followed by Student-Neuman-Keuls post-hoc test for each hour comparison) were observed following CS conditions at 09:00 hours (Fig. 1d) . Total sleep time during the light period was reduced significantly (P = 0.013) after CS (Cr: 37.2 AE 3.8%) when compared to prediet control measurements (54.9 AE 5.2%), whereas no changes were observed in the dark period (Cr: 22.9 AE 3.9%; prediet control: 20.3 AE 2.9%; P = 0.642). The reductions in TST during the light period are due to a significant decrease in NREM SWS (Cr: 31.1 AE 4.8%; prediet control: 46.3 AE 7.8%; P = 0.04), while REM sleep did not change significantly before and after CS (Cr: 6.1 AE 2.8% TST; prediet control: 8.7 AE 2.7% TST; P = 0.445). These results indicate that 4 weeks of CS affect sleep-wake behaviour by increased wakefulness and reduced NREM SWS. NREM delta activity did not change ª 2017 European Sleep Research Society significantly in both groups during 24 h of undisrupted control conditions.
Cr reduces homeostatic sleep pressure after sleep deprivation
Six hours of total SD during the light period (07:00-13:00 hours) increased sleep pressure, which increased microsleep leading to some NREM sleep in hour 6 of SD (12:00-13:00 hours) in our evaluations (undisrupted control, wake: 48.4 AE 8.3%; NREM: 38.24 AE 7.8%; hour 6 SD (12:00-13:00 hours), wake: 76.6 AE 2.5%; NREM:
14.1 AE 1.8%). During control diet conditions rats showed increased NREM and REM sleep within the first 2 h of recovery sleep, which was attenuated after 4 weeks on the Cr diet [NREM, prediet control: 61.1 AE 4.8% and 53.7 AE 3.2%; Cr: 21.7 AE 4.9% and 21.6 AE 4.2%; REM, prediet control: 17.4 AE 1.6 and 18.7 AE 1.8; Cr: 5.4 AE 2.2 and 9.9 AE 3.3)] (Fig. 2b,c) . CS rats showed a significant increase in wakefulness within the first 2 h of RS when compared to control conditions (wake, Cr: 72.9 AE 6.7% and 68.4 AE 6.8%; prediet control: 21.5 AE 5.4% and 27.6 AE 4.3%; P < 0.05). EEG NREM delta activity (0.5-4.5 Hz) was significantly lower in the first hour of RS (À66.3%; P = 0.028), and lower but not Figure 1 . Creatine (Cr) supplementation increases waking time in the light, not the dark period. Increased spontaneous waking time after Cr supplementation (CS): 4 weeks of oral CS increased wake time during the light period (+19.10%; P = 0.014) but not during the dark (P = 0.158) period. Non-rapid eye movement (NREM) slow wave sleep (SWS) decreased significantly by À15.14% in the same diurnal pattern (Cr: 31.1 AE 4.8%; prediet control: 46.3 AE 7.8% total sleep time (TST); P = 0.04), while REM sleep did not change significantly before and after CS (Cr: 6.1 AE 2.8%; prediet control: 8.7 AE 2.7%; P = 0.445); 24-h electroencephalograph (EEG) recordings were performed before [baseline (BL), black line] and after 4 weeks of oral Cr supplementation (Cr, red line) in the same animals (n = 6). (d) Wake time was increased in the initial hours during the light period. Significantly higher levels (*P < 0.05) were observed under CS conditions at 09:00 hours; (e) SWS was reduced during the beginning of the light period. Significantly lower levels (*P < 0.05) were observed at 09:00 and 10:00 hours when compared to BL. (f) REM sleep before and after Cr-supplementation remained unchanged. REM sleep increased significantly only at 13:00 hours after Cr-supplementation when compared to BL (*P < 0.05). (g) No changes were observed in NREM delta during spontaneous sleep-wake behaviour before and after Cr supplementation.
ª 2017 European Sleep Research Society statistically significant in the second hour (À32.7%) when compared to baseline conditions (Fig 2d) .
Effects of Cr supplementation on brain PCr and Cr levels
To address if 4 weeks of CS affect brain PCr and Cr concentrations in areas important for sleep and wake regulation, we measured both metabolites from brain tissue samples dissected from FC, BF, CCX and HIPP. Brain PCr and Cr concentrations did not differ significantly (P > 0.05) before and after 4 weeks of oral CS in all four tested brain regions (PCr, FC: +15.5 AE 2.0%; BF: +18.5 AE 0.7%; CCX: 15.7 AE 0.9%; HIP AE 1.0); however, a trend towards increased PCr concentrations in FC, BF, CCX and HIPP was observed in CS (Fig. 3 b) .
Reduced brain ATP concentrations after CS as Cr supplementation
Brain ATP concentrations were measured in FC, BF, CCX and HIPP at 10:00 hours at baseline and after 2 and 4 weeks of CS (Fig. 4) . ATP levels decreased significantly (ANOVA and Student-Newman-Keuls post-hoc test, P > 0.05) in FC (À51.94 AE 12.87%), BF (À45.6 AE 7.9%) and HIPP (À37.3 AE 3.5%) after 2 weeks of CS when compared to BL. In FC and HIPP, ATP levels declined further between weeks 2 and 4 (FC: À72.7 AE 13.8%; HIPP: À52.3 AE 4.9%; P > 0.05). No significant overall change was observed in CCX (ANOVA, P > 0.05) (Fig. 4a) . (Fig 4b) .
Cr supplementation reduces extracellular AD concentrations in the BF
[AD]ex correlates with EEG NREM delta activity
[AD]ex in the BF is known for its role in sleep-wake regulation. The levels of [AD]ex increase with increased sleepiness (Basheer et al., 1999 (Basheer et al., , 2004 Porkka-Heiskanen et al., 1997) Creatinine (Cr) supplementation diminishes sleep pressure after 6 h of sleep deprivation. Changes in wake, non-rapid eye movement (NREM) and REM sleep (RS) were observed during 6 h of sleep deprivation (SD) followed by 6 h of recovery sleep before and after 4 weeks of Cr supplementation. Wake time was significantly higher after Cr supplementation during the last hour of SD and the first 2 h of recovery sleep (RS) (a). NREM sleep was reduced significantly during the last hour of SD and the initial hours of RS (b), when REM sleep was reduced (c). NREM delta activity (0.5-4.5 Hz) was also reduced at the end of SD (6 h) and the first hour of RS (d), indicating a reduced homeostatic sleep pressure.
ª 2017 European Sleep Research Society significant positive correlation (Pearson) between [AD]ex levels in the BF and NREM delta activity (r = 0.520; P < 0.0005), therefore indicating a direct relationship between the nucleoside AD and homeostatic sleep pressure (Fig. 4c) .
DI SCUSSION
The current study provides evidence that prolonged oral CS increases time spent in wakefulness. The homeostatic sleep response was also attenuated in rats after 4 weeks on a CS diet with a concurrent attenuation in SD-induced increase in the levels of [AD]ex in BF. Both NREM sleep and NREM delta showed a significant reduction in the first hour of recovery sleep after 6 h SD when compared to the control (prediet) condition. The PCr levels show a tendency for increase, whereas the ATP levels decrease. Thus, CS can alter the molecular components associated with cellular energy metabolism and enhance wakefulness. Within the last decade, accumulating evidence indicates that Cr may be useful in the treatment of certain diseases. As Cr is involved in energy production and acts as an ATP shuttle from the inner mitochondria to the cytosol, Cr was theorized to be useful in diseases of mitochondria where energy production is altered (Andres et al., 2008) . CS has been shown to be beneficial in diseases in which there is mitochondrial dysfunction, such as Parkinson, Huntington, myopathy, encephalopathy, ALS and some types of depression (Andres et al., 2008; Klivenyi et al., 1999; Matthews et al., 1998; Persky and Brazeau, 2001) . Recent studies also suggest that CS improved psychomotor performance and mood state significantly following acute sleep deprivation (Cook et al., 2011; McMorris et al., 2006 McMorris et al., , 2007 .
The positive effects of Cr on behavioural functioning are due probably to changes in brain energy metabolism. The cellular Cr pool is maintained by nutritional intake and denovo synthesis which takes place in liver, kidney, pancreas and, to a lesser extent, in brain (Walker, 1979) .
Human studies have provided evidence that oral consumption of Cr yielded a statistically significant increase in total Cr in different brain regions, which was highly reversible, as evidenced by control measurements at least 3 months after the diet (Dechent et al., 1999; Lyoo et al., 2003) .
As neuronal activity is related to ATP usage at the expense of PCr (Cadoux-Hudson et al., 1989; Chen et al., 1997) , an increased PCr pool after CS may be used to produce ATP from PCr, required for neuronal activity upon demand.
Our finding that PCr increased, although marginally, over time in the Cr group suggests that increased brain Cr levels shifted the equilibrium in the Cr kinase reaction (Cr + ATP ↔ PCr + ADP + H+) towards the right, therefore resulting in a decreased intracellular ATP and subsequent extracellular AD production. We interpret our finding of decreased ATP not as ª 2017 European Sleep Research Society a decrease in the total high-energy phosphate reservoir, but as a reflection of a shift in metabolite concentrations to maintain equilibrium via the Cr kinase reaction.
The reduction in cellular ATP with Cr supplementation was also observed in in-vivo human magnetic resonance spectroscopy (MRS) studies, showing that the increase in brain Cr was associated with decreased ATP levels and an increase in inorganic phosphate levels (Lyoo et al., 2003) .
Reduced cellular ATP can affect [AD]ex concentrations by lacking the molecules needed for further AD production. Under natural conditions AD is produced by increased breakdown of ATP by hydrolytic cascades that occurs in the intra-and extracellular medium (Basheer et al., 2004; Burnstock et al., 2011) . Therefore, [AD]ex concentrations depend upon both release of intracellular AD by various transporters or breakdown of extracellular ATP, released from neurones and glia cells (Corriden and Insel, 2012) . After its release ATP is broken down rapidly to adenosine phosphate (ADP), adenosine monophosphate (AMP) and adenosine by ectonucleotidases (Burnstock and Verkhratsky, 2009) . The formation and concentration of adenosine is linked narrowly with neuronal metabolic activity, and [AD]ex concentration increases under conditions of increased energy demand, such as prolonged sleep deprivation.
Therefore, the observed reduction in [AD]ex during prolonged sleep deprivation in CS rats suggests an increase in the high-energy phosphate pool with a decrease in ATP levels through the CK equilibrium reaction and a subsequent reduced production and release of AD to the extracellular medium.
At the physiological level, [AD]ex is a well-known endogenous sleep-inducing substance and a homeostatic regulator of brain energy during sleep (Basheer et al., 2004; PorkkaHeiskanen et al., 1997) . The levels of [AD]ex increase during wakefulness when compared to sleep and increase even further with prolonged SD. Sleepiness, indicated by NREM delta activity, correlates positively with the levels of [AD]ex. Accordingly, we observed that 4 weeks of the CS diet resulted not only in attenuated levels of SD-induced [AD]ex, but also in decreased homeostatic sleep response (Fig. 5) .
In conclusion, the present study suggests that chronic CS can affect sleep-wake behaviour and reduce homeostatic sleep pressure after sleep deprivation through reductions in [AD]ex in the BF. Therefore, Cr might be a potential candidate to reduce the negative effects of insufficient sleep, which is extremely common in the general population. Further studies are needed to evaluate the effects of Cr on human sleep and behaviour associated with SD.
